Duvakitug for colitis, ulcerative

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 22 Sep 2025: Trial registered, NCT07185009
  2. 16 Jan 2026: Trial started, NCT07185009

The trials

NCT07185009: A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

State
Under way
Phase
Phase 3
People
751 planned
Started
16 Jan 2026
Primary completion
21 Sep 2028
Arms
Duvakitug - dose 1, Duvakitug - dose 2, Duvakitug - dose 3
Results
None posted
  1. 22 Sep 2025: Trial registered
  2. 16 Jan 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.